First 30 days
Full access to Svarene’s features. No payment information is required to begin.
Available now on the App Store
A clearer picture starts here.
Track what is changing, notice possible patterns, ask better questions, and bring an organized record to your next appointment.
For iPhone · 30 days of full access · No payment information required · Core tracking stays free
* Actual Svarene app UI.
About Svarene
Svarene
AI-powered perimenopause companionBuilt for the transition period trackers rarely understand: changing cycles, sleep disruption, brain fog, hot flashes, treatments, and the environmental context around them.
Svarene begins with validation, keeps the core record private on your phone, and uses data only to make your own experience easier to understand and discuss.
See how the app worksPlans at a glance
Begin with the full picture. Keep the essentials.
Your first 30 days include full access with no payment information required. After that, core daily logging remains free and Premium is optional.
Free essentials
Continue daily logging and the core free experience after the full-access preview ends.
Monthly Premium
$9.99 per month in the United States. Your App Store purchase sheet shows the local price before you subscribe.
Annual Premium
$59.99 per year in the United States. Subscriptions are optional and managed through your app-store account.
What comes with you
A small download. A more complete record.
Private core tracking
Your primary health record is designed to stay on your device.
Environmental context
See whether weather, pollen, pressure, or air quality repeatedly coincide with how you feel.
Vee, when you choose
Optional, consent-based general health education with clear safety boundaries.
Doctor-ready reports
Organize what you recorded into a clearer appointment conversation.
Private by design
Begin without handing over your identity.
Core tracking requires no account. No advertising SDKs. No health-data sales. Optional features explain what they share before you use them.
Android is in preparation. There is no public Google Play listing yet.